The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

According to The Business Research Company’s Extended-Release Drugs Global Market Report 2023, the extended-release drugs market is expected to show promising growth in the forecast period.

Five Key insights from the forecast include:

1. Market Size – The global extended-release drugs market size is expected to grow from $51.06 billion in 2022 to $57.11 billion in 2023 at a compound annual growth rate (CAGR) of 11.9%. The extended-release drugs market is expected to reach $88.22 billion in 2027 at a CAGR of 11.5%.
2. Major Driver – The increasing incidence of chronic conditions is expected to propel the growth of the extended-release drug market going forward.
3. Key Trend – Product innovation is a key trend gaining popularity in the extended-release drug market. Major companies operating in the extended-release drug market are developing innovative products to sustain their position in the market.
4. Largest Region – North America was the largest region in the extended-release drugs market in 2022.
5. Major Players – Major players in the extended-release drugs market are Pfizer Inc., AbbVie Inc., Novartis AG, Sanofi SA, GlaxoSmithKline PLC, AstraZeneca Plc, Gilead Sciences Inc., Boehringer Ingelheim International GmbH, Viatris Inc.

View More On The Extended-Release Drugs Market Report 2023:
https://www.thebusinessresearchcompany.com/report/extended-release-drugs-global-market-report

Key Extended-Release Drugs Market Segments
The global extended-release drugs market is segmented –
1) By Type: Sustained Release Drug, Controlled Release Drug
2) By Mode: Over-The-Counter, Prescription
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Mail Order Pharmacies, Drug Stores

Request A Sample Of The Global Extended-Release Drugs Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=12675&type=smp

Extended-release drugs are a dosage form made to release the medication over a longer time, at a predetermined rate, duration, and location, in a controlled manner. The drug can be taken less frequently than the immediate release form, and patients may take 1 to 2 doses each day instead of 3 to 4.

The Extended-Release Drugs Global Market Report 2023  offers a comprehensive overview on the extended-release drugs market size, growth rate, trends and drivers, opportunities, strategies, and competitor landscape. The countries covered in the extended-release drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The Table Of Content For The Extended-Release Drugs Market Include:
1. Extended-Release Drugs Market Executive Summary
2. Extended-Release Drugs Market Segments
3. Extended-Release Drugs Market Size And Extended-Release Drugs Market Growth Rate
4. Key Extended-Release Drugs Market Trends
5. Major Extended-Release Drugs Market Drivers
……
25. Key Mergers And Acquisitions In The Extended-Release Drugs Market
26. Top Extended-Release Drugs Companies
27. Extended-Release Drugs Market Opportunities And Strategies
28. Extended-Release Drugs Market, Conclusions And Recommendations
29. Appendix

View More Related Reports –
Drugs Of Abuse (DOA) Testing Global Market Report 2023
Sustained Release Excipients Global Market Report 2023
Drugs For Immunotherapy Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model